Sorry, this entry is only available in Polish.
Powiązane
SK&S advised Velocity Clinical Research on the acquisition of ClinMedica Research
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of its first site…
09 Feb 2024
SK&S advised Warburg Pincus on the proposed sale of Aion Bank and Vodeno
Sołtysiński Kawecki & Szlęzak (SK&S) advised Warburg Pincus on the Polish law aspects of the proposed sale of 100% of…
06 Aug 2024
Webinar in Ukrainian | Tax-efficient business activities in Poland
Join us for the third in a series of Ukrainian Desk webinars dedicated to tax-efficient business activities in Poland. During the…
19 Jun 2023
SK&S’ M&A team advised Miura Partners on the acquisition of a majority stake in Meditrans by Proclinic and on the establishment of a strategic joint venture
SK&S’ M&A team advised Miura Partners on the acquisition of a majority stake in Meditrans by Proclinic and on the…
17 Jan 2023
SK&S Advised Velocity Clinical Research on the acquisition of KO-MED Clinical Centers
SK&S’ transaction team advised Velocity Clinical Research Inc.—the leading multi-specialty clinical sites business, in the acquisition of KO-MED Clinical Centers—one…
14 Feb 2024
SK&S advised DataExpert on the purchase of 100% of shares in the Polish companies Media sp. z o.o. and Safesqr sp. z o.o.
Sołtysiński Kawecki & Szlęzak law firm advised DataExpert on the purchase of 100% of shares in the Polish companies conducting…
11 Jun 2024